Cancer Screening Firm Anpac Completes Series A Round

Sacramento, California-based cancer screening biotech firm Anpac Bio-Medical Science Co., Ltd. has completed series A round of funding from Shanghai Zhangjiang Science & Technology Investment Corporation, according to a company announcement. The round is worth several million U.S. dollars, says the statement.

Lyfe Capital, Sequoia Join $23M Series A+ Round In Burning Rock Biotech

Guangzhou-based cancer diagnostic start-up Burning Rock Biotech has completed RMB150 million (US$23 million) series A+ round of funding from Lyfe Capital, Sequoia Capital and Legend Star, according to a company announcement. The company says it will use the proceeds on its research and development efforts, as well as developing new products to meet patient demand.